Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Breast Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12716| Published Date: Jun-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Breast Ultrasound Market size stood at USD 2.9 billion in 2026 and is predicted to grow at a 13.49% CAGR from 2027 to 2036, reaching USD 10.28 billion by 2036. The industry revenue for 2027 is calculated at USD 3.23 billion.

Base Year Value (2026)
USD 2.9 billion
CAGR (2027-2036)
13.49%
Forecast Year Value (2036)
USD 10.28 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Breast Ultrasound Market Intelligence Snapshot

Regional Market Dynamics

  • North America accounted for a 37.84% market share in 2026, supported by advanced diagnostic imaging infrastructure, established screening pathways, and routine ultrasound use across hospitals and imaging centers.
  • Asia Pacific is expected to expand at a 15.68% CAGR as diagnostic access improves, hospital capacity grows, and ultrasound adoption increases across routine breast screening and follow-up care.

Segment Momentum

  • ABUS accounted for 62.18% of the market in 2026 by delivering standardized image acquisition, consistent workflows, and reliable examinations that support efficient screening and diagnostic imaging across healthcare facilities.
  • Diagnostics Imaging Laboratories are expanding fastest as demand grows for specialized imaging services offering streamlined workflows, higher imaging throughput, appointment efficiency, and dedicated diagnostic environments.

Market Expansion Drivers

  • Rising breast cancer incidence and screening awareness driving diagnostic imaging demand.
  • Growing adoption of automated breast ultrasound and AI-enabled imaging systems.
  • Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers.

Leading Market Participants

  • Key players in the breast ultrasound market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Hologic, Inc. (United States), FUJIFILM Holdings Corporation (Japan), SuperSonic Imagine SA (France), Delphinus Medical Technologies, Inc. (United States), Fukuda Denshi Co., Ltd. (Japan), Lunit Inc. (South Korea).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 2.9 billion
  • 2027 Estimated Market Size: USD 3.23 billion.
  • Projected Market Size: USD 10.28 billion by 2036
  • Growth Forecast: 13.49% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Automated Breast Ultrasound (ABUS) (Product) | Hospital (End Use)
  • Emerging Opportunity Segment: Conventional Breast Ultrasound (CBUS) (Product) | Diagnostics Imaging Laboratories (End Use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising breast cancer incidence and screening awareness driving diagnostic imaging demand

Increasing awareness of breast cancer screening and the need for earlier detection are strengthening diagnostic imaging requirements, supporting the breast ultrasound market growth across healthcare settings. Breast ultrasound provides a non-invasive imaging option that can complement other breast examination methods, particularly when further evaluation of suspicious findings or dense breast tissue is required. Greater public awareness of routine screening and increasing attention to early diagnosis are encouraging healthcare providers to expand diagnostic capabilities. Its ability to support real-time examination without ionizing radiation also makes ultrasound a useful modality for repeated assessment and targeted evaluation of breast abnormalities.

Growing adoption of automated breast ultrasound and AI-enabled imaging systems

Technological advances are reshaping breast imaging workflows, and the breast ultrasound market will benefit from greater adoption of automated systems and artificial intelligence-enabled capabilities. Automated breast ultrasound can improve examination consistency by systematically capturing breast images, while AI-based tools can assist clinicians in identifying and characterizing potentially abnormal findings. These technologies can support more efficient image interpretation, reduce variability associated with manual examinations, and help integrate advanced imaging into screening and diagnostic workflows. Increasing interest in digital healthcare and computer-assisted diagnostics is encouraging providers to evaluate these systems for improving clinical efficiency and imaging support.

Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers

The expansion of decentralized healthcare delivery is creating additional opportunities for breast imaging outside traditional hospital environments, which will boost the breast ultrasound market demand. Outpatient facilities and mobile diagnostic centers can use ultrasound systems to provide breast examinations closer to patients, improving access for populations that may face geographic or logistical barriers to hospital-based imaging. Portable and compact ultrasound equipment also supports deployment in locations where large imaging infrastructure may not be practical. Greater emphasis on convenient diagnostic services and earlier clinical evaluation is encouraging healthcare providers to incorporate breast imaging into community-based and ambulatory care models.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising breast cancer incidence and screening awareness driving diagnostic imaging demand 2.20% High North America, Europe High Near Term
Growing adoption of automated breast ultrasound and AI-enabled imaging systems 2.00% Moderate North America, Asia Pacific High Mid Term
Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers 1.60% Moderate Asia Pacific, North America Emerging Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Breast Ultrasound Market
Largest Region
North America
37.84% Market Share in 2026

North America (Largest Region)

North America held the largest share of the breast ultrasound market at 37.84% in 2026, supported by advanced diagnostic infrastructure, strong adoption of breast imaging technologies, and growing emphasis on early detection. Healthcare providers are increasingly integrating ultrasound into breast assessment pathways, particularly where supplemental imaging is needed to improve diagnostic evaluation. The region's established network of hospitals and diagnostic centers, combined with access to advanced imaging equipment and skilled medical professionals, supports consistent utilization. Continued focus on improving diagnostic accuracy and expanding access to non-invasive imaging is further strengthening regional demand.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing regional market, driven by expanding healthcare infrastructure, rising awareness of breast health, and improving access to diagnostic services. Increasing investment in hospitals and imaging centers is enabling broader adoption of ultrasound technologies, while greater emphasis on early diagnosis is encouraging more women to seek screening and diagnostic evaluation. Growing healthcare expenditure and modernization of medical facilities are also supporting the deployment of advanced imaging systems. As diagnostic capabilities become more accessible across developing healthcare markets, demand for breast ultrasound is gaining momentum throughout the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Precision Diagnostic Support

Germany emphasizes breast ultrasound as an important complementary imaging modality, particularly for patients requiring additional diagnostic evaluation. Investments are directed toward high-resolution systems and efficient integration within hospital imaging departments.

France 🇫🇷

Structured Diagnostic Pathways

France utilizes breast ultrasound as part of coordinated diagnostic pathways that support comprehensive breast care. Demand is centered on systems that improve examination efficiency and provide reliable imaging for supplemental assessments.

Italy 🇮🇹

Expanding Imaging Accessibility

Italy is focusing on improving access to breast imaging services through broader deployment of ultrasound equipment across healthcare settings. Providers are seeking versatile systems that support both routine examinations and specialized diagnostic requirements.

Japan 🇯🇵

High-Resolution Screening Tools

Japan is prioritizing advanced breast ultrasound technologies that enhance screening accuracy and support dense breast assessment. Healthcare facilities continue to adopt compact and high-performance systems suited to routine diagnostic workflows.

South Korea 🇰🇷

Technology-Driven Screening

South Korea's breast ultrasound market is characterized by rapid adoption of technologically advanced imaging platforms. Providers are incorporating artificial intelligence and improved visualization tools to strengthen diagnostic confidence and patient management.

United States 🇺🇸

Advanced Imaging Integration

The U.S. breast ultrasound market is increasingly focused on integrating advanced imaging technologies into screening and diagnostic pathways. Healthcare providers are adopting systems with improved image quality and workflow capabilities to support early detection initiatives.

Segment Analysis

Segment Leadership and Growth Trends

Breast Ultrasound Market Share (%), by Product, 2026

Automated Breast Ultrasound (ABUS)
Conventional Breast Ultrasound (CBUS)

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Product Segment Analysis: Automated Breast Ultrasound (ABUS) (Largest Segment) vs Conventional Breast Ultrasound (CBUS) (Fastest-Growing Segment)

Automated breast ultrasound (ABUS) accounted for 62.18% share in 2026, making it the leading product segment in the breast ultrasound market. Its automated scanning approach supports more standardized breast imaging and can improve workflow consistency compared with highly operator-dependent examination methods. Growing interest in reproducible imaging, screening efficiency, and advanced diagnostic workflows is reinforcing adoption of automated ultrasound technologies.

Conventional breast ultrasound (CBUS) is the fastest-growing product segment as healthcare providers continue to value the flexibility of operator-guided imaging for targeted breast evaluation. Its ability to support real-time assessment and focused examination of specific areas makes it useful in diagnostic settings, while broader access to ultrasound equipment and continued demand for complementary breast imaging are supporting its expanding utilization.

End Use Segment Analysis: Hospital (Largest Segment) vs Diagnostics Imaging Laboratories (Fastest-Growing Segment)

Hospitals dominated the breast ultrasound market with a 51.41% share in 2026, reflecting their central role in breast disease diagnosis, screening, treatment planning, and follow-up care. Hospitals offer access to multidisciplinary clinical teams and complementary diagnostic resources, allowing breast ultrasound to be integrated into broader patient evaluation pathways and supporting consistent demand for imaging services.

Diagnostics imaging laboratories represent the fastest-growing end-use segment as diagnostic services increasingly expand beyond traditional hospital settings. Specialized imaging facilities can provide focused examination services, streamlined workflows, and convenient access to diagnostic testing, supporting greater utilization of breast ultrasound as demand for accessible and timely imaging continues to increase.

Segment Sub-Segment Largest Segment Fastest Growing
Product Conventional Breast Ultrasound (CBUS), Automated Breast Ultrasound (ABUS) Automated Breast Ultrasound (ABUS) Conventional Breast Ultrasound (CBUS)
End Use Hospital, Diagnostics Imaging Laboratories, Others Hospital Diagnostics Imaging Laboratories
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Top players in the breast ultrasound market:

1. GE HealthCare Technologies Inc. (United States)

2. Koninklijke Philips N.V. (Netherlands)

3. Siemens Healthineers AG (Germany)

4. Canon Medical Systems Corporation (Japan)

5. Hologic Inc. (United States)

6. FUJIFILM Holdings Corporation (Japan)

7. SuperSonic Imagine SA (France)

8. Delphinus Medical Technologies Inc. (United States)

9. Fukuda Denshi Co. Ltd. (Japan)

10. Lunit Inc. (South Korea)

The breast ultrasound market is advancing with improvements in imaging resolution and diagnostic precision. Innovation in portable and high-frequency ultrasound systems is enhancing clinical usability. Continuous development in imaging algorithms is supporting more accurate and early-stage detection capabilities.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
GE HealthCare Technologies Inc. (United States)
Koninklijke Philips N.V. (Netherlands)
Siemens Healthineers AG (Germany)
Canon Medical Systems Corporation (Japan)
Hologic Inc. (United States)
FUJIFILM Holdings Corporation (Japan)
SuperSonic Imagine SA (France)
Delphinus Medical Technologies Inc. (United States)
Fukuda Denshi Co. Ltd. (Japan)
Lunit Inc. (South Korea).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Samsung Medison May-26 Samsung Medison formed a strategic partnership with HistoSonics to integrate its R20 ultrasound system with the Edison platform. This collaboration enables seamless connectivity between diagnostic imaging and therapeutic ultrasound technologies, marking a strategic expansion for Samsung into the emerging field of ultrasound-guided, non-invasive therapeutic interventions.
iSono Health Apr-26 iSono Health commercially launched ATUSA, an FDA-cleared, wearable 3D breast ultrasound system. This automated platform is designed to decentralize breast imaging by reducing reliance on specialized sonographers and conventional hospital-based infrastructure, representing a significant shift toward portable, high-throughput breast cancer screening accessibility.
RadNet Apr-26 RadNet, through its DeepHealth subsidiary, acquired See-Mode Technologies to incorporate AI-powered ultrasound imaging solutions into its clinical operations. This strategic acquisition enhances RadNet's diagnostic capabilities and strengthens its position in the competitive AI-driven medical imaging market, facilitating more efficient ultrasound interpretation and clinical workflow integration.
GE HealthCare Apr-26 GE HealthCare launched the Ivenia ABUS Premium, an AI-enhanced automated breast ultrasound system. The platform is engineered to optimize supplemental breast screening workflows, improving diagnostic throughput and imaging consistency. This release underscores the company’s strategic commitment to leveraging artificial intelligence to address clinical inefficiencies in large-scale breast cancer screening programs.
iCAD Apr-26 iCAD entered a strategic reseller partnership with Koios Medical to integrate AI-driven diagnostic technologies across mammography and ultrasound platforms. This initiative creates a multi-modality breast cancer detection ecosystem, allowing for more cohesive diagnostic workflows that improve clinical decision-making from initial screening through to final assessment.
BeamWorks Apr-26 BeamWorks secured regulatory approval in South Korea for its CadAI-B software, an AI-assisted diagnostic tool for breast cancer detection. The regulatory clearance facilitates the commercial deployment of advanced, software-based diagnostic support in clinical environments, contributing to the broader market trend toward AI-augmented breast imaging and improved diagnostic precision.
USM Hospital Apr-26 USM Hospital deployed GE HealthCare’s Invenia ABUS 2.0, marking the first installation of this automated breast ultrasound system on Malaysia’s east coast. This strategic infrastructure investment significantly upgrades the region’s breast cancer screening capacity, reflecting a broader trend of expanding access to advanced, standardized automated ultrasound technology in emerging healthcare markets.
Lily MedTech Apr-26 Lily MedTech announced advancements in its breast imaging portfolio, specifically focusing on ultrasound mammogram technology. This development aims to enhance early-stage breast cancer detection by utilizing ultrasound-based screening as a primary modality, challenging conventional diagnostic paradigms and signaling a potential shift in long-term breast imaging clinical practices.
Hologic, Inc. Nov-23 Hologic, Inc. introduced Genius AI Detection 2.0, an advanced software solution designed to improve breast cancer detection rates while simultaneously reducing false-positive markings. The release serves as a strategic update to the company's AI-driven diagnostic portfolio, improving the accuracy of clinical screening workflows and enhancing the competitive utility of its imaging hardware.
Hologic, Inc. Sep-23 Hologic, Inc. partnered with Bayer to jointly develop and distribute contrast-enhanced mammography (CEM) solutions globally. This strategic alliance combines Hologic’s imaging hardware expertise with Bayer’s contrast media capabilities, aiming to expand diagnostic options for breast cancer detection and address the specific imaging needs of patients with dense breast tissue.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Breast Ultrasound Market — Custom Segments

Segment Sub-Segment
Clinical Use Screening, Diagnostic Evaluation, Biopsy Guidance & Interventional Procedures, Treatment Monitoring
Procurement Model Direct Capital Purchase, Leasing & Equipment Financing, Managed Equipment Services, Pay-Per-Use & Outsourced Imaging
Operator Type Radiologists, Sonographers, Breast Surgeons & Specialists, Other Trained Clinical Personnel

Breast Ultrasound Market — Custom TOC

Custom Chapter Custom Details
Breast Imaging Workflow Optimization Analysis
  • Breast Imaging Workflow and Operational Requirements
  • Examination Efficiency and Clinical Productivity Priorities
  • Workflow Integration Across Screening and Diagnostic Settings
  • Opportunities to Improve Imaging Operations
Screening Program Expansion Opportunities
  • Breast Screening Access and Program Development
  • Screening Infrastructure and Provider Capacity Requirements
  • Adoption Barriers Across Underserved Settings
  • Expansion Opportunities for Ultrasound-Based Screening
AI Integration Impact Assessment
  • AI Integration Across Breast Ultrasound Workflows
  • Clinical Decision Support and Image Interpretation Applications
  • Provider Adoption and Workflow Integration Requirements
  • Implementation Barriers and Emerging AI Opportunities

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How large is the breast ultrasound market?

The market revenue for breast ultrasound is anticipated at USD 3.23 billion in 2027.

What is the anticipated CAGR of the breast ultrasound industry?

Breast Ultrasound Market size stood at USD 2.9 billion in 2026 and is predicted to grow at a 13.49% CAGR from 2027 to 2036, reaching USD 10.28 billion by 2036.

How are automation and AI influencing purchasing decisions in the breast ultrasound market?

Healthcare providers are investing in automated and AI-enabled ultrasound systems to standardize image acquisition, improve workflow consistency, reduce interpretation burden, and support scalable breast imaging across multiple care sites.

Why is point-of-care imaging accelerating growth in the breast ultrasound market?

Outpatient and mobile diagnostic centers are increasing demand for compact ultrasound systems that enable faster evaluations, same-visit assessments, and improved patient access without requiring large hospital-based imaging infrastructure.

Why is Automated Breast Ultrasound (ABUS) the largest product segment in the breast ultrasound market?

ABUS accounted for 62.18% of the market in 2026 by delivering standardized image acquisition, consistent workflows, and reliable examinations that support efficient screening and diagnostic imaging across healthcare facilities.

Why are Diagnostics Imaging Laboratories the fastest-growing end-use segment in the breast ultrasound market?

Diagnostics Imaging Laboratories are expanding fastest as demand grows for specialized imaging services offering streamlined workflows, higher imaging throughput, appointment efficiency, and dedicated diagnostic environments.

Why does North America lead the breast ultrasound market?

North America accounted for a 37.84% market share in 2026, supported by advanced diagnostic imaging infrastructure, established screening pathways, and routine ultrasound use across hospitals and imaging centers.

What factors are accelerating breast ultrasound market growth in Asia Pacific?

Asia Pacific is expected to expand at a 15.68% CAGR as diagnostic access improves, hospital capacity grows, and ultrasound adoption increases across routine breast screening and follow-up care.

Who holds a significant market share in the breast ultrasound landscape?

Key players in the breast ultrasound market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Hologic, Inc. (United States), FUJIFILM Holdings Corporation (Japan), SuperSonic Imagine SA (France), Delphinus Medical Technologies, Inc. (United States), Fukuda Denshi Co., Ltd. (Japan), Lunit Inc. (South Korea).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →